Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

31 structures for P05979

Entry ID Method Resolution Chain Position Source
1CQE X-ray 310 A A/B 21-600 PDB
1DIY X-ray 300 A A 32-584 PDB
1EBV X-ray 320 A A 33-583 PDB
1EQG X-ray 261 A A/B 21-600 PDB
1EQH X-ray 270 A A/B 21-600 PDB
1FE2 X-ray 300 A A 25-600 PDB
1HT5 X-ray 275 A A/B 33-583 PDB
1HT8 X-ray 269 A A/B 33-583 PDB
1IGX X-ray 310 A A 25-600 PDB
1IGZ X-ray 290 A A 25-600 PDB
1PGE X-ray 350 A A/B 25-600 PDB
1PGF X-ray 450 A A/B 25-600 PDB
1PGG X-ray 450 A A/B 25-600 PDB
1PRH X-ray 350 A A/B 33-586 PDB
1PTH X-ray 340 A A/B 25-600 PDB
1Q4G X-ray 200 A A/B 32-584 PDB
1U67 X-ray 310 A A 1-600 PDB
2AYL X-ray 200 A A/B 32-584 PDB
2OYE X-ray 285 A P 1-600 PDB
2OYU X-ray 270 A P 1-600 PDB
3KK6 X-ray 275 A A/B 32-584 PDB
3N8V X-ray 305 A A/B 32-584 PDB
3N8W X-ray 275 A A/B 32-584 PDB
3N8X X-ray 275 A A/B 32-584 PDB
3N8Y X-ray 260 A A/B 32-584 PDB
3N8Z X-ray 290 A A/B 32-584 PDB
4O1Z X-ray 240 A A/B 32-600 PDB
5U6X X-ray 293 A A/B 1-600 PDB
5WBE X-ray 275 A A/B 1-600 PDB
7JXT X-ray 335 A A/B 32-584 PDB
AF-P05979-F1 Predicted AlphaFoldDB

6 variants for P05979

Variant ID(s) Position Change Description Diseaes Association Provenance
97 R>H No
164 D>G No
456 R>Q No
520 E>K No
520 E>Q No
525 M>I No

No associated diseases with P05979

1 regional properties for P05979

Type Name Position InterPro Accession
domain EGF-like domain 32 - 70 IPR000742

Functions

Description
EC Number 1.14.99.1 Miscellaneous
Subcellular Localization
  • Endoplasmic reticulum membrane; Multi-pass membrane protein
  • Microsome membrane; Multi-pass membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
intracellular membrane-bounded organelle Organized structure of distinctive morphology and function, bounded by a single or double lipid bilayer membrane and occurring within the cell. Includes the nucleus, mitochondria, plastids, vacuoles, and vesicles. Excludes the plasma membrane.

6 GO annotations of molecular function

Name Definition
dioxygenase activity Catalysis of an oxidation-reduction (redox) reaction in which both atoms of oxygen from one molecule of O2 are incorporated into the (reduced) product(s) of the reaction. The two atoms of oxygen may be distributed between two different products. [DOI:10.1016/S0040-4020(03)00944-X, GOC:bf]
heme binding Binding to a heme, a compound composed of iron complexed in a porphyrin (tetrapyrrole) ring.
metal ion binding Binding to a metal ion.
peroxidase activity Catalysis of the reaction: a donor + a peroxide = an oxidized donor + 2 H2O.
prostaglandin-endoperoxide synthase activity Catalysis of the reaction: arachidonate + donor-H2 + 2 O2 = prostaglandin H2 + acceptor + H2O.
protein homodimerization activity Binding to an identical protein to form a homodimer.

5 GO annotations of biological process

Name Definition
cyclooxygenase pathway The chemical reactions and pathways by which prostaglandins are formed from arachidonic acid, and in which prostaglandin-endoperoxide synthase (cyclooxygenase) catalyzes the committed step in the conversion of arachidonic acid to the prostaglandin-endoperoxides PGG2 and PGH2.
inflammatory response The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages.
prostaglandin biosynthetic process The chemical reactions and pathways resulting in the formation of prostaglandins, any of a group of biologically active metabolites which contain a cyclopentane ring.
regulation of blood pressure Any process that modulates the force with which blood travels through the circulatory system. The process is controlled by a balance of processes that increase pressure and decrease pressure.
response to oxidative stress Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MSRQSISLRF PLLLLLLSPS PVFSADPGAP APVNPCCYYP CQHQGICVRF GLDRYQCDCT
70 80 90 100 110 120
RTGYSGPNCT IPEIWTWLRT TLRPSPSFIH FLLTHGRWLW DFVNATFIRD TLMRLVLTVR
130 140 150 160 170 180
SNLIPSPPTY NIAHDYISWE SFSNVSYYTR ILPSVPRDCP TPMDTKGKKQ LPDAEFLSRR
190 200 210 220 230 240
FLLRRKFIPD PQSTNLMFAF FAQHFTHQFF KTSGKMGPGF TKALGHGVDL GHIYGDNLER
250 260 270 280 290 300
QYQLRLFKDG KLKYQMLNGE VYPPSVEEAP VLMHYPRGIP PQSQMAVGQE VFGLLPGLML
310 320 330 340 350 360
YATIWLREHN RVCDLLKAEH PTWGDEQLFQ TARLILIGET IKIVIEEYVQ QLSGYFLQLK
370 380 390 400 410 420
FDPELLFGAQ FQYRNRIAME FNQLYHWHPL MPDSFRVGPQ DYSYEQFLFN TSMLVDYGVE
430 440 450 460 470 480
ALVDAFSRQP AGRIGGGRNI DHHILHVAVD VIKESRVLRL QPFNEYRKRF GMKPYTSFQE
490 500 510 520 530 540
LTGEKEMAAE LEELYGDIDA LEFYPGLLLE KCHPNSIFGE SMIEMGAPFS LKGLLGNPIC
550 560 570 580 590
SPEYWKASTF GGEVGFNLVK TATLKKLVCL NTKTCPYVSF HVPDPRQEDR PGVERPPTEL